AI tells a patient on warfarin that INR monitoring every 2 weeks is sufficient after a dose change, ignoring need for more frequent checks
ID: medical/warfarin-inr-monitoring-frequency
Version Compatibility
| Version | Status | Introduced | Deprecated | Notes |
|---|---|---|---|---|
| Warfarin Sodium 5mg Tablets USP | active | — | — | — |
| Coumadin 5mg | active | — | — | — |
| Jantoven 5mg | active | — | — | — |
| INRatio PT/INR Monitor | active | — | — | — |
Root Cause
After warfarin dose adjustment, INR should be rechecked within 3-7 days due to the drug's narrow therapeutic index and variable response; waiting 2 weeks risks subtherapeutic or supratherapeutic INR, increasing thromboembolic or bleeding risk.
generic中文
华法林剂量调整后，由于药物治疗窗窄且反应可变，应在3-7天内复查INR；等待2周可能导致INR低于或高于治疗范围，增加血栓栓塞或出血风险。
Official Documentation
https://www.uptodate.com/contents/warfarin-dosing-and-monitoring-beyond-the-basicsWorkarounds
-
90% success After any warfarin dose adjustment (increase or decrease), schedule INR check within 3-7 days. Use a standardized algorithm (e.g., the '5-7 day rule'). If INR is within target range (e.g., 2.0-3.0 for most indications), extend to every 2 weeks, then monthly after two consecutive stable values.
After any warfarin dose adjustment (increase or decrease), schedule INR check within 3-7 days. Use a standardized algorithm (e.g., the '5-7 day rule'). If INR is within target range (e.g., 2.0-3.0 for most indications), extend to every 2 weeks, then monthly after two consecutive stable values.
-
85% success For patients on long-term stable warfarin, use a point-of-care INR device (e.g., CoaguChek) for weekly self-monitoring with remote dose adjustment via anticoagulation clinic. This reduces clinic visits while maintaining safety.
For patients on long-term stable warfarin, use a point-of-care INR device (e.g., CoaguChek) for weekly self-monitoring with remote dose adjustment via anticoagulation clinic. This reduces clinic visits while maintaining safety.
中文步骤
在每次华法林剂量调整（增加或减少）后，安排在3-7天内复查INR。使用标准化算法（如“5-7天规则”）。如果INR在目标范围内（如大多数适应症2.0-3.0），延长至每两周一次，然后连续两次稳定后改为每月一次。
对于长期服用稳定剂量华法林的患者，使用即时INR检测设备（如CoaguChek）进行每周自我监测，通过抗凝门诊远程调整剂量。这可在减少门诊就诊次数的同时保持安全性。
Dead Ends
Common approaches that don't work:
-
80% fail
The patient may have been subtherapeutic for 10+ days, but doubling dose could cause overshoot to >5.0 and major bleeding. Need to check at 3-7 days after adjustment.
-
70% fail
Even stable patients can have INR fluctuations due to diet, illness, or other medications. Monthly monitoring is standard for stable patients, but more frequent checks are needed after any dose change.